Thursday, November 21, 2024
Subscribe American Journal of Medicine Free Newsletter
CommentaryAlpert's EditorialsCollateral Damage from COVID: Commentary & Research

Collateral Damage from COVID: Commentary & Research

Joseph S. Alpert, MD
AJM Editor-in-Chief, Joseph S. Alpert, MD

After more than 2 years of waxing and waning, the COVID pandemic is quieting down. We are all holding our breaths and hoping that another variant does not appear and lead to another surge of hospitalizations. The pandemic has caused global chaos, pain, misery, death, and economic deprivation. Hospitals were stressed to their limits, and face to face events disappeared. During hospitalization peaks, quarantine measures resulted in periods of “no visitors.” Locking out visitors and family increased levels of misery for patients and their significant others. During my inpatient attending rotations at that time, I was witness to a cascade of painful episodes involving critically ill and dying individuals whose only contact with their families was by phone or tablet. These situations were agonizing for patients, nurses, and physicians.

In this issue of The American Journal of Medicine, two reports document hospital collateral damage done to patients and their loved ones by the pandemic. The palliative care team at the Tokyo Medical Center in Tokyo, Japan, reported that during the time of restricted visitation, total doses of narcotics given for pain relief increased significantly compared with a similar period before the COVID-induced limitations. Read: “Do Hospital Visit Restrictions Cause Increase in the Doses of Morphine in Terminal Care? Spiritual Pain and Palliative Care in the COVID-19 Pandemic.”
This study observed that restricted visitation increased patient spiritual pain factors and caused significant patient stress at the end of life. Iness and co-workers at the Virginia Commonwealth University in Richmond, Virginia, report a systematic review of available data concerning the impact of restrictive hospital visitor policies on patient, family and visitor, and healthcare provider well-being during the period of COVID hospital lockdown. Like the findings of the Japanese study, these investigators found that restrictive hospital policies were associated with failure to address the needs of patients, their visitors, and healthcare providers in various clinical environments. Read: “The Effect of Hospital Policies on Patients, Their Visitors, and Health Care Providers During the COVID-19 Pandemic: A Systematic Review.”
These observations were consistent with what I observed on numerous occasions during hospital lockdown. One example was particularly poignant. An 86-year-old woman who only spoke Spanish had a large and supportive family. She was nearing the end of her life secondary to hepatic and renal failure. My ward team and the palliative care consultant were very uncomfortable with the fact that no family member was allowed to be with the patient during her final hours of life. We appealed to our hospital administration asking for an exception to the imposed visitor restriction. The administration granted a compassionate allowance, and the patient’s oldest daughter stayed with the patient during her last 48 hours. Many on our team and the staff caring for this woman were moved to tears by this episode. Unfortunately, many other patients never had this merciful opportunity.
During this period of painful lockdown, I was constantly reminded of Portia’s soliloquy in Shakespeare’s The Merchant of Venice:
The quality of mercy is not strained;
It droppeth as the gentle rain from heaven
Upon the place beneath. It is twice blest;
It blesseth him that gives and him that takes:
‘Tis mightiest in the mightiest; it becomes
The throned monarch better than his crown…
It made me hope that if we are ever forced to repeat the events of the COVID pandemic, we would somehow devise an original and merciful solution to alleviate suffering and dying alone. Perhaps, unique protective protocols for visitors or holographic visitations might alleviate some of the misery that we observed during the height of the lockdown.
As always, I respond to all communications about this or other commentaries at jalpert@email.arizona.edu.
To read this article in its entirety, please visit our website.

– Joseph S. Alpert, MD

“Collateral Damage” was originally published in the October 2022 issue of The American Journal of Medicine.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...